Krystal Biotech is trading 4.05% up now at $355.56 as biotechnology shares strengthen broadly.

  • The XBI sector ETF is up 2.06%, providing a meaningful industry tailwind.
  • No fresh company-specific announcement appears on Krystal Biotech’s investor-relations release page for August 25, 2026.
  • Its latest listed release is the August 3 second-quarter update, making sector momentum the best attribution.